Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report

Retrospective analysis of the long-term results of a randomized controlled trial comparing alemtuzumab (ALEM) and antithymocyte globulin (ATG) as induction therapy in simultaneous pancreas-kidney transplantation (SPK) to address individualized long-term immunosuppression. Between 2006 and 2010 a tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Bösmüller, Claudia, Messner, Franka, Margreiter, Christian, Öllinger, Robert, Maglione, Manuel, Oberhuber, Rupert, Scheidl, Stefan, Neuwirt, Hannes, Öfner, Dietmar, Margreiter, Raimund, Schneeberger, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Letter To Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363467/
https://www.ncbi.nlm.nih.gov/pubmed/30679414
http://dx.doi.org/10.12659/AOT.911712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363467/
https://www.ncbi.nlm.nih.gov/pubmed/30679414
http://dx.doi.org/10.12659/AOT.911712

Ejemplares similares